Search

everythinglearnresearchcommunity

for

Search:↓

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

TS-13 speeds up hair regrowth after chemotherapy.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

CS12192 effectively treats alopecia areata with better safety than current options.

Less differentiated melanoma cells are more vulnerable to a type of cell death, which could improve cancer treatments.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

Females had more chemotherapy side effects than males, with many being preventable.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

AMPK activation may reduce melanoma risk in red-haired individuals.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Recent findings advanced understanding of cancer mechanisms and potential treatments.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Dogs exposed to their owners' hormone therapy developed hair loss, but symptoms resolved after stopping the therapy.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

A patient with complete hair loss regrew all her hair using tofacitinib.